
ASH 2025 LBA BRUIN-CLL 313 Update: Pirtobrutinib vs Bendamustine/Rituximab in 1L CLL
Two Onc Docs
00:00
Outro
Sam and Kareen thank listeners, give board study wishes, and invite feedback on social media.
Play episode from 10:46
Transcript

Sam and Kareen thank listeners, give board study wishes, and invite feedback on social media.